Literature DB >> 102913

Evaluation of assay methods for hepatitis B surface (HBsAg) antigen and its antibody (anti-HBs) in viral hepatitis B (VHB)-HBsAg-positive.

V Mudrić, B Vuković, E Dimić, R Borota.   

Abstract

The sensitivity of methods for the detection of HBsAg and its anti-HBs was compared in serial 1200 sera samples from 30 patients with VHB-HBsAg-positive. HBsAg was tested by gel-diffusion (GD), counter-immunoelectrophoresis (CIE), reversed haemogglutination (rHA), redioimmunoassay (RIA), and enzyme immunoassay (EIA). RIA and EIA methods are statistically significantly more sensitive compared with the other methods (P less than 0.0005). By these methods the minimal concentrations of HBsAg in sera can be proved. Although there is no statistically significant difference in the sensitivity between RIA and EIA, the latter is more sensitive if the subtype ay-HBsAg is considered (12 sera samples). In 24 patients the subtype was ay, in two ad, and in four it could not be differentiated. In 70% of patients anti-HBs was proved by RIA and in 10% by CIE, i.e., in 73% and 9% of sera samples, respectively. In 117 sera samples of these patients the sensitivity of RIA and EIA was compared for determination of anti-HBs. No statistically significant difference between the methods for determination of anti-HBs was found (50.42%: 40.17%). No immune response to HBsAg has been observed in 9 cases, but 6 of them have remained permanent carriers of this antigen.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 102913     DOI: 10.1007/bf02121150

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  18 in total

1.  [HB antigen demonstration, antibody formation and cellular immune reaction in the clinical course of hepatitis B infection (proceedings)].

Authors:  U Kaboth
Journal:  Zentralbl Bakteriol Orig A       Date:  1976-08

2.  [Etiology of hepatitis B. Preliminary results of a cooperative study (proceedings)].

Authors:  R Thomssen; W Gerlich; B Stamm; R Biswas; P R Lorenz; M Majer; E Weinmann; W Arnold; G Hess; W Wepler; O Klinge
Journal:  Zentralbl Bakteriol Orig A       Date:  1976-08

3.  Antibody to hepatitis-B-virus core in man.

Authors:  J H Hoofnagle; R J Gerety; L F Barker
Journal:  Lancet       Date:  1973-10-20       Impact factor: 79.321

4.  New specificities in Australia antigen positive sera distinct from the Le Bouvier determinants.

Authors:  L O Magnius; J A Espmark
Journal:  J Immunol       Date:  1972-11       Impact factor: 5.422

5.  Virus-like particles in serum of patients with Australia-antigen-associated hepatitis.

Authors:  D S Dane; C H Cameron; M Briggs
Journal:  Lancet       Date:  1970-04-04       Impact factor: 79.321

6.  DNA of a human hepatitis B virus candidate.

Authors:  W S Robinson; D A Clayton; R L Greenman
Journal:  J Virol       Date:  1974-08       Impact factor: 5.103

7.  [Australia antigen and anicteric viral hepatitis].

Authors:  V Mudric; B Vukovic; E Dimic; J Kacaki; Z Radujkov; D Miskov
Journal:  G Mal Infett Parassit       Date:  1971-12

8.  [Demonstration of hepatitis B (surface) antigen. A comparison of different serological methods (author's transl)].

Authors:  W Lange; H Köhler; J Apodaca
Journal:  Dtsch Med Wochenschr       Date:  1975-03-14       Impact factor: 0.628

9.  Reversed haemagglutination tests for the detection of hepatitis B antigen.

Authors:  A H Schuurs; J Kacaki
Journal:  Vox Sang       Date:  1974       Impact factor: 2.144

10.  Clinical and serological analysis of transfusion-associated hepatitis.

Authors:  H J Alter; P V Holland; A G Morrow; R H Purcell; S M Feinstone; Y Moritsugu
Journal:  Lancet       Date:  1975-11-01       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.